Pedro Aíde

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

Pedro L. Alonso, Jahit Sacarlal, John J. Aponte et al. · The Lancet · 2004 · 746 citations

Vaccination, Vaccine Safety, Plasmodium Falciparum Infection +9

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

Daniel E. Neafsey, Michal Juraska, Trevor Bedford et al. · New England Journal of Medicine · 2015 · 437 citations · Full text

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

Pedro L. Alonso, Jahit Sacarlal, John J. Aponte et al. · The Lancet · 2005 · 410 citations

Vaccination, Plasmodium Falciparum Disease, Global Health +4

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

Michael White, Robert Verity, Jamie T. Griffin et al. · The Lancet Infectious Diseases · 2015 · 344 citations · Full text

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

John J. Aponte, Pedro Aíde, Montse Renom et al. · The Lancet · 2007 · 274 citations

Vaccination, Vaccine Safety, Vaccine Development +6